Miriam E. Tucker

November 30, 2020 We and our partners process data to provide: List of Partners (vendors)

Positive findings from a phase 2 trial were followed by disappointing news; however, new guidelines aim to help clinicians with off-label prescribing.

July 13, 2026 Should all adults with diabetes, including those who are asymptomatic, be screened for peripheral vascular disease (PAD)?

July 20, 2026 People with type 1 diabetes (T1D) use alcohol and marijuana just as often as the general population, but discussions of the unique risks and mitigation strategies don't often happen in clinical encounters.

July 23, 2026 Progress is ongoing in efforts to reduce the burden of immune suppression for people with type 1 diabetes (T1D) receiving islet cell transplants, thereby potentially allowing more patients to receive them.

Two experts debated this question at the American Diabetes Association 2026 Scientific Sessions.

The voluntary recall of multiple tablet dosages is for sub-potency.

Consensus document from three European societies covers nutritional, functional, and psychological considerations for incretin-based therapies in adults.

July 31, 2026 Rising temperatures appear to significantly increase the short-term risk for hypoglycemia among adults with type 1 diabetes (T1D), new research suggested.

An analysis of nearly 33 million continuous glucose monitoring readings links hotter temperatures to more frequent hypoglycemia in adults with type 1 diabetes.